Nonso Ezema, MD
Internal Medicine · Lima, OHNPI 1588075626
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Novartis at 26.5% of the total. 2025 is the largest year on record at $3,953, 8.2 times the $484 reported in 2019. Among internal medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 142 payments — averaging $65.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- F. Hoffmann-la Roche AG$2K
- Amgen$2K
- AstraZeneca$1K
- AbbVie$898
- Johnson & Johnson$471
- plus $554 from 8 others
Across 88 payments — averaging $18,407 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$590K
- Genentech, Inc.$360K
- Vertex$224K
- Amgen$163K
- AstraZeneca$134K
- Hoffmann-la Roche Limited$63K
- plus $87K from 5 others
What the payments were for
- Travel & lodging$4,47648%
- Food & beverage$4,78851%
- Education$651%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 27 | $2,471 |
| F. Hoffmann-la Roche AG | 4 | $1,943 |
| Amgen | 6 | $1,723 |
| AstraZeneca | 18 | $1,270 |
| AbbVie(2 entities) | 39 | $898 |
| Johnson & Johnson | 23 | $471 |
| Pfizer | 9 | $159 |
| E.r. Squibb & Sons, L.L.C. | 6 | $146 |
| Astellas Pharma US Inc | 2 | $79 |
| Janssen Scientific Affairs, LLC | 1 | $58 |
| Gilead | 3 | $51 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $31 |
| Teleflex LLC | 1 | $18 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEFLARO$107
How this compares
$9,329 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 12 | $102 |
| Prednisone | 13 | $37 |
| Cephalexin | 11 | $21 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Lima
- Eric KirschnerLima$37K
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
- Daniel WeissMentor$406K
- Richard KimDayton$326K
- Marina MagreyCleveland$312K
- Lisa LarkinCincinnati$276K
- Gregg FaimanMayfield Hts$274K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.